Nu Skin Enterprises Changes Fiscal Year End

TL;DR

NU SKIN just changed its fiscal year end to Oct 31, effective immediately. Big reporting shift coming.

AI Summary

Nu Skin Enterprises, Inc. filed an 8-K on November 1, 2024, reporting a change in its fiscal year end from December 31 to October 31. This change is effective as of October 31, 2024. The filing also includes financial statements and exhibits.

Why It Matters

This change in fiscal year end could impact the timing of financial reporting and investor analysis, potentially affecting how the company's performance is evaluated throughout the year.

Risk Assessment

Risk Level: low — The filing is a routine administrative change regarding the company's fiscal reporting period and does not indicate any immediate operational or financial distress.

Key Players & Entities

• NU SKIN ENTERPRISES, INC. (company) — Registrant
• October 31, 2024 (date) — Effective date of fiscal year change
• December 31 (date) — Previous fiscal year end
• November 1, 2024 (date) — Filing date of the 8-K

FAQ

Filing Documents

• ef20037801_8k.htm (8-K) — 37KB
• ef20037801_ex3-1.htm (EX-3.1) — 143KB
• 0001140361-24-045001.txt ( ) — 348KB
• nus-20241031.xsd (EX-101.SCH) — 4KB
• nus-20241031_lab.xml (EX-101.LAB) — 22KB
• nus-20241031_pre.xml (EX-101.PRE) — 16KB
• ef20037801_8k_htm.xml (XML) — 4KB

03

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On October 31, 2024, the Board of Directors of Nu Skin Enterprises, Inc. (the "Company") approved and adopted the Sixth Amended and Restated Bylaws of the Company (as so amended and restated, the "Bylaws"), which became effective upon such approval and adoption. The amendments to the Bylaws, among other things: Update the procedural and disclosure requirements for stockholders intending to nominate director candidates or propose other business (other than proposals submitted under Rule 14a-8 under the Securities Exchange Act of 1934) at stockholder meetings, including, without limitation, to: o clarify that the number of nominees that a stockholder may nominate at a stockholder meeting cannot exceed the number of directors to be elected at such meeting, o require disclosure of specific information with respect to (i) the record stockholder, (ii) any beneficial owner on whose behalf the proposal or nomination was made, and (iii) their respective affiliates and associates (each, a "Proponent"), o require stockholder nominees to submit a D&O questionnaire and a representation and agreement with respect to, among otherings, voting commitments, compensation arrangements, compliance with the Company's policies applicable to directors, o permit the Company to request additional information regarding the independence, background and experience of a stockholder nominee, o require stockholders proposing business other than nominations to provide the text of the proposed business and to disclose any material interest of any Proponent in such business, o require that the record stockholder or a qualified representative thereof attend the meeting to propose any nomination or business, o clarify the times at which the information provided in a stockholder's notice must be updated and supplemented, and o clarify the procedures and requirements applicable to stockholder

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. 3.1 Sixth Amended and Restated Bylaws of Nu Skin Enterprises, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NU SKIN ENTERPRISES, INC. (Registrant) /s/ James D. Thomas James D. Thomas Chief Financial Officer Date: November 1, 2024

View Full Filing

View this 8-K filing on SEC EDGAR